Radical cell therapy tested for devastating autoimmune diseases
NCT ID NCT06822881
Summary
This early-stage study is testing a new treatment called CT1190B CAR-T cell therapy for adults with severe lupus or scleroderma that hasn't responded to standard treatments. Doctors will collect a patient's own immune cells, modify them in a lab to potentially fight the disease, and then infuse them back. The main goals are to see if the treatment is safe and to look for early signs that it can reduce disease activity.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC SCLEROSIS (SSC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beijing GoBroad Hospital
RECRUITINGBeijing, Beijing Municipality, 102200, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.